nonprofit logo

Glycosyn Health Initiatives Inc C/O Newburg & Company Llp

Learn about this cause: Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 263983845 ✦ Waltham, MA ✦ Designated as a 501(c)(3)

Shop smarter and support your favorite cause at the same time! With the Give Freely browser extension, you'll automatically save money with coupons, and partner stores will donate to your chosen charity - at no extra cost to you. Start giving back with a single click. It's safe, free, and spam-free, guaranteed!

Overview

What is Glycosyn Health Initiatives Inc C/O Newburg & Company Llp?

Glycosyn Health Initiatives Inc C/O Newburg & Company Llp is a dedicated biotechnology organization based on therapeutics and diagnostics. Their primary mission is to combat the high morbidity and mortality rates among children in third world countries, which are often caused by infant and childhood diseases. They strive to achieve this goal by implementing innovative treatments and cutting-edge technologies. Glycosyn Health Initiatives Inc aims to make a significant impact globally, focusing on reducing the burden of these diseases on children in less developed regions.


Official website here: www.glycosynhealthinitiatives.org

Is Glycosyn Health Initiatives Inc C/O Newburg & Company Llp legitimate?

Glycosyn Health Initiatives Inc C/O Newburg & Company Llp is a legitimate nonprofit organization registered as a 501(c)(3) entity. Glycosyn Health Initiatives Inc C/O Newburg & Company Llp submitted a form 990EZ, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.


Official website here: www.glycosynhealthinitiatives.org

What is the mission statement of Glycosyn Health Initiatives Inc C/O Newburg & Company Llp?

Glycosyn Health Initiatives Inc., under the guidance of Newburg & Company LLP, is a biotechnology organization with a mission focused on combating infant and childhood diseases, which are major contributors to morbidity and mortality rates in underdeveloped countries. Their primary goal is to implement innovative treatments and technological advancements to lessen the impact of these diseases on children globally. By doing so, the organization aims to significantly improve the health and well-being of children in these regions.


Official website here: www.glycosynhealthinitiatives.org

Who is the CEO of Glycosyn Health Initiatives Inc C/O Newburg & Company Llp?

Unavailable


Official website here: www.glycosynhealthinitiatives.org

What is the revenue of Glycosyn Health Initiatives Inc C/O Newburg & Company Llp?

Glycosyn Health Initiatives Inc C/O Newburg & Company Llp's revenue in 2022 was $0.


Official website here: www.glycosynhealthinitiatives.org

Who are the executives of Glycosyn Health Initiatives Inc C/O Newburg & Company Llp and what are their salaries?


Here are 6 key members and their salaries:


Steven Cohen (President & Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Howard M Newburg (Clerk & Cfo)
  • Compensation: $0
  • Related: $0
  • Other: $0
David S Newburg (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Vidar J Jorgenson (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Gary Cohen (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Phillips L Kuhl (Director & Treasurer)
  • Compensation: $0
  • Related: $0
  • Other: $0


Official website here: www.glycosynhealthinitiatives.org

Where can I find the form 990EZ for Glycosyn Health Initiatives Inc C/O Newburg & Company Llp?

Glycosyn Health Initiatives Inc C/O Newburg & Company Llp's most recent form 990EZ was submitted in 2022 and can be accessed here.


Official website here: www.glycosynhealthinitiatives.org

Learn more at the official website: www.glycosynhealthinitiatives.org

Mission Statement of Glycosyn Health Initiatives Inc C/O Newburg & Company Llp

Glycosyn Health Initiatives Inc., a biotechnology therapeutics and diagnostics organization, is committed to making a significant impact in reducing the impact of infant and childhood diseases, which are the primary causes of morbidity and mortality among children in third world countries. This nonprofit organization is dedicated to implementing innovative treatments and technologies to tackle these prevalent health issues. By focusing on these regions, Glycosyn Health Initiatives Inc. aims to improve the overall health and well-being of children, ultimately reducing the high mortality rates associated with these diseases. The organization's mission is driven by a passion to implement new therapies and diagnostic tools, thereby making a substantial difference in the lives of children worldwide.

Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!

Impact




October, 2024

Glycosyn Health Initiatives Inc C/O Newburg & Company Llp plays a crucial role in addressing the pressing health challenges faced by infants and children, particularly in third world countries where diseases significantly contribute to high morbidity and mortality rates. By focusing on biotechnology therapeutics and diagnostics, Glycosyn is at the forefront of developing innovative treatments and technologies aimed at improving health outcomes for vulnerable populations.

The organization dedicates its efforts to research and implement effective solutions that can reduce the burden of childhood diseases, making a tangible difference in communities that are often underserved. Through its initiatives, Glycosyn not only contributes to the immediate health needs but also works towards long-term improvements in healthcare systems, ultimately fostering a healthier future for children globally. Its commitment to advancing medical science and access to care exemplifies the potential for positive impact in the realm of global health.




This information is meant to be a general summary of Glycosyn Health Initiatives Inc C/O Newburg & Company Llp. Please take the time to review official sources before making any decisions based upon the content provided here.


Financials

This financial information is from Propublica.

Revenue
$0 (2022)
Expenses
$672 (2022)
Efficiency

Other financial information:

This information is from the most recently submitted tax form from this organization, which was in 2022.

    Assets and Liabilities:

    • Total Assets: $51,247
    • Total Liabilities: $38,000
    • Net Assets: $13,247

    Want to help this charity, for free? You can click here to learn more about Give Freely

    Organization Details

    Main Address

    95 SAWYER ROAD SUITE 120, WALTHAM, MA, 02453

    NTEE Category

    Code: Q33 - International

    If you are a representative of Glycosyn Health Initiatives Inc C/O Newburg & Company Llp and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.